Literature DB >> 21325757

Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis.

Takumi Yoshino1, Natsuko Kusunoki, Nahoko Tanaka, Kaichi Kaneko, Yoshie Kusunoki, Hirahito Endo, Tomoko Hasunuma, Shinichi Kawai.   

Abstract

OBJECTIVE: Body fat is an important source of hormones and cytokines (adipokines) that not only regulate the energy balance, but also regulate the inflammatory and immune responses. This study investigated the association of clinical conditions with serum levels of adipokines in patients with rheumatoid arthritis.
METHODS: Serum levels of resistin, leptin, and adiponectin were measured by enzyme-linked immunosorbent assay in 141 patients (110 women) who fulfilled the 1987 revised criteria of the American Rheumatism Association for the diagnosis of rheumatoid arthritis and in 146 normal controls (124 women). Then the correlations between adipokine levels and clinical parameters were evaluated.
RESULTS: The serum resistin level did not differ between the patients and controls. However, serum leptin levels were significantly higher in male and female rheumatoid arthritis patients than in the corresponding controls, while the serum adiponectin level was significantly higher in female patients than in female controls. Multivariate analysis revealed that predictors of an elevated resistin level were female sex and C-reactive protein (CRP), while the leptin level was related to the body mass index and CRP. Predictors of an elevated adiponectin level were the use of prednisolone and CRP, however, CRP was negatively associated with adiponectin in patients with rheumatoid arthritis.
CONCLUSION: The serum levels of resistin and leptin were positively associated with CRP level in patients with rheumatoid arthritis, suggesting that these adipokines may act as pro-inflammatory cytokines in this disease. The serum adiponectin level was elevated in the patients, however, it was negatively associated with CRP level. In addition, the serum levels of resistin, leptin, and adiponectin were also associated with female sex, BMI and the use of prednisolone, respectively.
© 2011 The Japanese Society of Internal Medicine

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325757     DOI: 10.2169/internalmedicine.50.4306

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  44 in total

1.  Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.

Authors:  Yuri Masui; Yoshihide Asano; Kaname Akamata; Naohiko Aozasa; Shinji Noda; Takashi Taniguchi; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Hayakazu Sumida; Yoshihiro Kuwano; Koichi Yanaba; Yayoi Tada; Makoto Sugaya; Shinichi Sato; Takafumi Kadono
Journal:  Rheumatol Int       Date:  2013-10-19       Impact factor: 2.631

2.  Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

Authors:  Qing Huang; Sha-Sha Tao; Yu-Jing Zhang; Chao Zhang; Lian-Ju Li; Wei Zhao; Meng-Qin Zhao; Peng Li; Hai-Feng Pan; Chen Mao; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-05-03       Impact factor: 2.980

3.  Leptin as an obesity marker in rheumatoid arthritis.

Authors:  Maria Fernanda Brandão de Resende Guimarães; Marcus Vinícius Melo de Andrade; Carla Jorge Machado; Érica Leandro Marciano Vieira; Maria Raquel da Costa Pinto; Antônio Lúcio Teixeira Júnior; Adriana Maria Kakehasi
Journal:  Rheumatol Int       Date:  2018-06-11       Impact factor: 2.631

4.  Resistin as a potential marker of renal disease in lupus nephritis.

Authors:  J Hutcheson; Y Ye; J Han; C Arriens; R Saxena; Q-Z Li; C Mohan; T Wu
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

5.  Fat-Produced Adipsin Regulates Inflammatory Arthritis.

Authors:  Yongjia Li; Wei Zou; Jonathan R Brestoff; Nidhi Rohatgi; Xiaobo Wu; John P Atkinson; Charles A Harris; Steven L Teitelbaum
Journal:  Cell Rep       Date:  2019-06-04       Impact factor: 9.423

6.  Clinical potential of resistin as a novel prognostic biomarker for cellulitis.

Authors:  Ayse Erturk; Medine Cumhur Cure; Erkan Cure; Aysel Kurt; Aysegul Copur Cicek; Suleyman Yuce
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

Review 7.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression.

Authors:  S M H Fadda; S M Gamal; N Y Elsaid; A M Mohy
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

9.  Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity.

Authors:  Tamer A Gheita; Iman I El-Gazzar; Reem I El Shazly; Abeer M Nour El-Din; Enas Abdel-Rasheed; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-08-11       Impact factor: 8.317

10.  Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms.

Authors:  Ping Li; Li Yang; Cui-Li Ma; Bo Liu; Xin Zhang; Rui Ding; Li-qi Bi
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.